Clinical Infectious Diseases
@cidjournal.bsky.social
The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @idsainfo.bsky.social
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods
✅ Just Accepted
🔗 https://bit.ly/4jD20f1
✅ Just Accepted
🔗 https://bit.ly/4jD20f1
January 8, 2026 at 2:55 AM
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods
✅ Just Accepted
🔗 https://bit.ly/4jD20f1
✅ Just Accepted
🔗 https://bit.ly/4jD20f1
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin
✅ Just Accepted
🔗 https://bit.ly/49IzMw0
✅ Just Accepted
🔗 https://bit.ly/49IzMw0
January 7, 2026 at 10:03 PM
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin
✅ Just Accepted
🔗 https://bit.ly/49IzMw0
✅ Just Accepted
🔗 https://bit.ly/49IzMw0
Guidance on the management of asymptomatic blood donors who test positive for Babesia
✅ Just Accepted
🔗 https://bit.ly/498Odcv
✅ Just Accepted
🔗 https://bit.ly/498Odcv
January 6, 2026 at 10:38 PM
Guidance on the management of asymptomatic blood donors who test positive for Babesia
✅ Just Accepted
🔗 https://bit.ly/498Odcv
✅ Just Accepted
🔗 https://bit.ly/498Odcv
January 6, 2026 at 7:45 PM
Congratulations once again to CID’s 2024 reviewers of the year. Awardees were selected through IDSA’s reviewer recognition and rewards program and originally announced in January 2025.
Learn more about the program and become a peer reviewer yourself: https://bit.ly/4aoKJ6S
Learn more about the program and become a peer reviewer yourself: https://bit.ly/4aoKJ6S
December 30, 2025 at 10:56 PM
Congratulations once again to CID’s 2024 reviewers of the year. Awardees were selected through IDSA’s reviewer recognition and rewards program and originally announced in January 2025.
Learn more about the program and become a peer reviewer yourself: https://bit.ly/4aoKJ6S
Learn more about the program and become a peer reviewer yourself: https://bit.ly/4aoKJ6S
Long-term clinical outcomes after hospitalization for acute respiratory illness due to respiratory syncytial virus (RSV)
✅ Just Accepted
🔗 https://bit.ly/4jbpZSa
✅ Just Accepted
🔗 https://bit.ly/4jbpZSa
December 30, 2025 at 7:29 PM
Long-term clinical outcomes after hospitalization for acute respiratory illness due to respiratory syncytial virus (RSV)
✅ Just Accepted
🔗 https://bit.ly/4jbpZSa
✅ Just Accepted
🔗 https://bit.ly/4jbpZSa
Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon
✅ Just Accepted
🔗 https://bit.ly/48SADKg
✅ Just Accepted
🔗 https://bit.ly/48SADKg
December 29, 2025 at 10:29 PM
Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon
✅ Just Accepted
🔗 https://bit.ly/48SADKg
✅ Just Accepted
🔗 https://bit.ly/48SADKg
Do We Need a Bone Biopsy for Managing Diabetic Foot Osteomyelitis?
✅ Just Accepted
🔗 https://bit.ly/4sf42WD
✅ Just Accepted
🔗 https://bit.ly/4sf42WD
December 29, 2025 at 8:17 PM
Do We Need a Bone Biopsy for Managing Diabetic Foot Osteomyelitis?
✅ Just Accepted
🔗 https://bit.ly/4sf42WD
✅ Just Accepted
🔗 https://bit.ly/4sf42WD
December 29, 2025 at 12:22 AM
Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa
✅ Just Accepted
🔗 https://bit.ly/3Y6fJB5
✅ Just Accepted
🔗 https://bit.ly/3Y6fJB5
December 28, 2025 at 7:55 PM
Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa
✅ Just Accepted
🔗 https://bit.ly/3Y6fJB5
✅ Just Accepted
🔗 https://bit.ly/3Y6fJB5
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Patient Perspectives
✅ Just Accepted
🔗 https://bit.ly/3MKGIQk
✅ Just Accepted
🔗 https://bit.ly/3MKGIQk
December 27, 2025 at 10:12 PM
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Patient Perspectives
✅ Just Accepted
🔗 https://bit.ly/3MKGIQk
✅ Just Accepted
🔗 https://bit.ly/3MKGIQk
Nocardia farcinica as a potential Pathogen Associated with a Clinical Subtype of Kikuchi-Fujimoto Disease
✅ Just Accepted
🔗 https://bit.ly/4jaOOxK
✅ Just Accepted
🔗 https://bit.ly/4jaOOxK
December 26, 2025 at 11:30 PM
Nocardia farcinica as a potential Pathogen Associated with a Clinical Subtype of Kikuchi-Fujimoto Disease
✅ Just Accepted
🔗 https://bit.ly/4jaOOxK
✅ Just Accepted
🔗 https://bit.ly/4jaOOxK
December 26, 2025 at 8:49 PM
Reposted by Clinical Infectious Diseases
I heard you calling, on the megaphone. You wanna see the micro. As legend has it, you like the PO.
academic.oup.com/cid/advance-...
🫶 Behind a paywall but LMK and I can DM you the full proof.
academic.oup.com/cid/advance-...
🫶 Behind a paywall but LMK and I can DM you the full proof.
December 23, 2025 at 12:51 PM
I heard you calling, on the megaphone. You wanna see the micro. As legend has it, you like the PO.
academic.oup.com/cid/advance-...
🫶 Behind a paywall but LMK and I can DM you the full proof.
academic.oup.com/cid/advance-...
🫶 Behind a paywall but LMK and I can DM you the full proof.
Routine HIVRNA Testing During Injectable Cabotegravir and Oral PrEP Use
✅ Just Accepted
🔗 https://bit.ly/3KKhpNL
✅ Just Accepted
🔗 https://bit.ly/3KKhpNL
December 24, 2025 at 9:50 PM
Routine HIVRNA Testing During Injectable Cabotegravir and Oral PrEP Use
✅ Just Accepted
🔗 https://bit.ly/3KKhpNL
✅ Just Accepted
🔗 https://bit.ly/3KKhpNL
Why are gonorrhea case rates declining in the US? A research agenda.
✅ Just Accepted
🔗 https://bit.ly/44FUmKB
✅ Just Accepted
🔗 https://bit.ly/44FUmKB
December 24, 2025 at 12:11 PM
Why are gonorrhea case rates declining in the US? A research agenda.
✅ Just Accepted
🔗 https://bit.ly/44FUmKB
✅ Just Accepted
🔗 https://bit.ly/44FUmKB
Incidence of community-acquired pneumonia and herpes zoster in people with HIV based on CD4-count and age in the current antiretroviral therapy era: a longitudinal cohort study.
✅ Just Accepted
🔗 https://bit.ly/4pIeCUp
✅ Just Accepted
🔗 https://bit.ly/4pIeCUp
December 23, 2025 at 9:52 PM
Incidence of community-acquired pneumonia and herpes zoster in people with HIV based on CD4-count and age in the current antiretroviral therapy era: a longitudinal cohort study.
✅ Just Accepted
🔗 https://bit.ly/4pIeCUp
✅ Just Accepted
🔗 https://bit.ly/4pIeCUp
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200
✅ Just Accepted
🔗 https://bit.ly/3MLLvku
✅ Just Accepted
🔗 https://bit.ly/3MLLvku
December 23, 2025 at 7:21 PM
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200
✅ Just Accepted
🔗 https://bit.ly/3MLLvku
✅ Just Accepted
🔗 https://bit.ly/3MLLvku
December 22, 2025 at 10:42 PM
Can doxycycline prophylaxis indirectly reduce congenital syphilis?
✅ Just Accepted
🔗 https://bit.ly/3N9fe6W
✅ Just Accepted
🔗 https://bit.ly/3N9fe6W
December 22, 2025 at 8:34 PM
Can doxycycline prophylaxis indirectly reduce congenital syphilis?
✅ Just Accepted
🔗 https://bit.ly/3N9fe6W
✅ Just Accepted
🔗 https://bit.ly/3N9fe6W
ALARA in Antimicrobial Stewardship: Adapting Radiation Safety Principles to Address Antibiotic Overuse
✅ Just Accepted
🔗 https://bit.ly/4qiuFrV
✅ Just Accepted
🔗 https://bit.ly/4qiuFrV
December 21, 2025 at 6:21 PM
ALARA in Antimicrobial Stewardship: Adapting Radiation Safety Principles to Address Antibiotic Overuse
✅ Just Accepted
🔗 https://bit.ly/4qiuFrV
✅ Just Accepted
🔗 https://bit.ly/4qiuFrV
Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection
✅ Just Accepted
🔗 https://bit.ly/3MJYrYc
✅ Just Accepted
🔗 https://bit.ly/3MJYrYc
December 20, 2025 at 10:33 PM
Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection
✅ Just Accepted
🔗 https://bit.ly/3MJYrYc
✅ Just Accepted
🔗 https://bit.ly/3MJYrYc
Moving closer to patient-level risk-adjustment for hospital antimicrobial use
✅ Just Accepted
🔗 https://bit.ly/4paxxGr
✅ Just Accepted
🔗 https://bit.ly/4paxxGr
December 20, 2025 at 6:40 PM
Moving closer to patient-level risk-adjustment for hospital antimicrobial use
✅ Just Accepted
🔗 https://bit.ly/4paxxGr
✅ Just Accepted
🔗 https://bit.ly/4paxxGr
Disease Trends and Mortality from Invasive Pneumococcal Disease: A Long-Term Population-Based Study
✅ Just Accepted
🔗 https://bit.ly/48OWyAz
✅ Just Accepted
🔗 https://bit.ly/48OWyAz
December 19, 2025 at 11:45 PM
Disease Trends and Mortality from Invasive Pneumococcal Disease: A Long-Term Population-Based Study
✅ Just Accepted
🔗 https://bit.ly/48OWyAz
✅ Just Accepted
🔗 https://bit.ly/48OWyAz
H.U.S.T.L.E: A Consult Fitness Guide for Infectious Diseases Providers
✅ Just Accepted
🔗 https://bit.ly/4iEYXlS
✅ Just Accepted
🔗 https://bit.ly/4iEYXlS
December 19, 2025 at 9:10 PM
H.U.S.T.L.E: A Consult Fitness Guide for Infectious Diseases Providers
✅ Just Accepted
🔗 https://bit.ly/4iEYXlS
✅ Just Accepted
🔗 https://bit.ly/4iEYXlS